ӳ����ý

For patients with a rare brain tumor known as craniopharyngioma, the treatment options are slim — and often hazardous. Although the tumor is usually not aggressive, its location is perilous. Growing at the base of the skull near the pituitary gland, the tumor compresses parts of the brain as it enlarges, causing vision and learning problems and endocrine dysfunction, as well as morbid obesity. There is currently no drug to shrink the tumor, so the only options are surgical removal and radiation, which can leave patients with serious, lasting problems.

It’s part of human nature: we look at ourselves in the mirror and see links to the past. “Those bright green eyes?” we think. “Those came from grandma.” “The cleft chin? That’s from dad’s side.” Our instinct, of course, is to attribute notable traits to close relatives – those that we know personally or through family history. The reality, however, is that the genetics that influence our traits – or “phenotypes” – could date back generations. Some may have been introduced into human lineages more than 40,000 years ago.

The annual Forbes was revealed this week, and two members of the ӳ����ý community, Cigall Kadoch and Aleksander Kostic, were named to the list. Now in its third year, ’30 under 30’ recognizes the brightest young talents in 15 different fields, including science and healthcare, technology and finance.

In science, sometimes you need to dive deep to see the big picture. Scientists at the ӳ����ý have demonstrated this time and again, enabling biological discoveries by generating dense maps, such as the survey of thousands of epigenetic marks on DNA across the human genome conducted as part of the .

What: A team led by ӳ����ý scientists has uncovered how the cancer drug lenalidomide works. Lenalidomide has been used for nearly a decade to treat multiple myeloma and other disorders that affect blood cells found in bone marrow, but its exact mechanism of action hadn’t previously been understood.